BioSpace News Archive

Deals

Novan Enters into Agreement to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 Protection

Novan, Inc. and its wholly owned subsidiary, EPI Health, LLC, announced that it has entered into a stalking horse asset purchase agreement with Ligand Pharmaceuticals, Inc. prior to filing voluntary petitions for relief under chapter 11 of title 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware.

July 17, 2023
·
7 min read
Pharm Country

Elevar Therapeutics Announces FDA Acceptance for Filing of New Drug Application for Rivoceranib in Combination with Camrelizumab as a First-line Treatment for Unresectable Hepatocellular Carcinoma

Elevar Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) accepted a new drug application (NDA) for its investigational drug rivoceranib.

July 17, 2023
·
6 min read
Devyser’s NGS products for monitoring of kidney and stem cell transplanted patients receive IVDR approvals

Devyser’s novel test for detecting donor-derived cell-free DNA in blood samples from kidney-transplant patients and its product for screening and follow-up of stem cell transplanted patients fulfill IVDR requirements in Europe.

July 17, 2023
·
3 min read